Recreational and medicinal cannabis has been on the market and in the news for quite some time and for good reason. The market is growing rapidly as science catches up to this ancient herbal medicine. Companies around the world from cultivators to manufacturers to suppliers of equipment and wholesaler’s retailers and packaging companies and much, much more have been growing exponentially as this industry expands to meet international demand. In addition, we are only still at the beginning.

If you have been doing homework, you know that humans have an Endocannabinoid system (ECS) this system regulates our health and well-being by moderating homeostasis.

The function of the system interacts completely and organically with the cannabinoids found in cannabis. By simply heating cannabis, the medicinal properties are activated and released.

Thus, this is the reason why cannabis shares around the world are growing so quickly. It makes sense that all humans and their pets will have some form of non-psychotropic cannabinoid either in their food, beverages or as medicine such as in consumer oil or casual form. 
CBD is one of these great components, which has taken the global market by storm. It stands for cannabidiol and is a non-psychotropic cannabinoid contained in cannabis. This cannabinoid is extracted and used for medication for a merit of things ranging from pain treatment to insomnia and to nausea.

Regular Marijuana Use Changes Anesthesia Needs

OCTOBER 15, 2019
The recreational use of marijuana is currently legal in 11 states—Alaska, California, Colorado, Illinois, Maine, Massachusetts, Michigan, Nevada, Oregon, Vermont and Washington—and also in Washington, D.C. Several other states allow marijuana use for medicinal reasons. State legislative changes that have legalized marijuana have brought both medical opportunities and challenges. Read More

Global cannabis stocks are plunging as investors shift from upstream to downstream markets
October 18, 2019
Dr Agarwal investors cannabis stocks oversupply Canada Australia market
Many cannabis stocks in the Canadian market have lost at least half their value over the past year as investors move away from companies exposed to cultivation of the plant.

In the few short years since cannabis companies first floated on stock exchanges around the world, they have developed a reputation for being volatile and high risk.

At the start, stocks exploded in value, peaking around the start of 2018. Then the hype started to fizzle, but industry experts said 2019 was the year cannabis was supposed to take off again.

However, it seems most cannabis stocks in the mature market of Canada – where the drug was legalised for medical purposes in 2001 and for recreational use a year ago – have lost at least half their value over the past year.

Compared to January, stock market data shows multi-billion-dollar companies such as Canopy Growth Corp (NYSE: CGC, TSE: WEED) and Cronos Group (TSE: CRON) have dropped by more than 50%, with Tilray (NASDAQ: TLRY) plummeting by a whopping $6.7 billion, or 74%.

Medical cannabis industry expert Dr Sud Agarwal spoke with Small Caps about the reasons behind Canada’s struggling cannabis stocks and whether Australia could be heading in the same direction.

Dr Agarwal is an internationally-recognised key opinion leader in the industry who is the chief executive officer and co-founder. Read More

Buying cannabis licenses on secondary market more of a sure bet than applying for state business permits

Published October 17, 2019 | By Margaret Jackson

As the marijuana industry matures and companies expand, many smaller, original growers and retailers are putting their licenses up for sale through the secondary market – much like selling a house.

The growing trend is giving cannabis entrepreneurs a new avenue to secure a valuable business permit versus going through the state application process, which can prove costly and time-consuming. Moreover, there’s no guarantee an applicant will secure a license.

“The average group will spend $300,000 to $1.5 million pursuing the license and not get it,” said Avis Bulbulyan, CEO of Siva Enterprises, a Glendale, California-based cannabis business development and solutions firm. Read More

Invest Cannabis Australia

Invest Cannabis Australia one of the more recent countries to legalize medical cannabis and in 2019, the Australian Capital Territory legislated recreational marijuana for the first time.

Invest in Cannabis

The market is dynamic and rapidly expanding as the science catches up. The next big wave is already on its way. Invest In Cannabis  the global cannabis market is predicted to reach over US$500 billion. 

Invest In Marijuana The global marijuana sector is hotting up with countries like Canada, Uruguay, Jamaica and many others opening up legislation to cultivate and produce cannabis products. 

CBD is the new pain management option for the 21st century. Investment Cannabis has hit the limelight in recent years as plant based medicine continues to make big changes to the way patients treat a series of illnesses and ailments. 

Buy Cannabis Shares

Buy Cannabis Shares is subsidiary  of OrganicMarijuana.com and provides information and opportunities for investors to enter into the global cannabis market. 

Invest Cannabis Industry an overview of investment opportunities in the global cannabis market.
Invest Cannabis Market

Invest Cannabis Market  is your go to website resource to review and find unique cannabis companies to invest in. A broad perspective on investing in the cannabis market.

Buy Cannabis Shares

Buy Cannabis Shares  we all know that cannabis is the hot subject and product right  now and there is a long way for the market to grow. Buying cannabis shares has never been easier.